Pikin Oleg, Ryabov Andrey, Sokolov Victor, Glushko Vladimir, Kolbanov Konstantin, Telegina Larisa, Amiraliev Ali, Barmin Vitaliy
Department of Thoracic Surgery, P. A. Hertzen Research Institute of Oncology, Moscow, Russia.
Department of Thoracoabdominal Surgery, P. A. Hertzen Research Institute of Oncology, Moscow, Russia.
Ann Thorac Surg. 2017 Dec;104(6):1846-1851. doi: 10.1016/j.athoracsur.2017.06.050. Epub 2017 Oct 17.
The aim of the study was to evaluate the efficacy of a combined approach of endoscopic resection followed by pure bronchoplasty without any pulmonary resection in patients with endobronchial carcinoids.
We applied a two-stage technique, endoscopic resection first followed by pure bronchoplasty, to 25 patients (10 men, 15 women) with endobronchial carcinoid tumors. The median age was 32.4 years (range, 19 to 64). The indications for this technique were pure endobronchial carcinoid without lymph node involvement. Tumor was located on the right side in 18 patients (72%), and on the left in 7 patients (28%). Flexible bronchoscopy was carried out in all patients as the first-stage procedure for debulking and searching for a true pedicle of the tumor. Different types of pure bronchoplasty were performed as the second-stage surgery with systematic mediastinal lymph node dissection.
The resection was complete (R0) in all cases. Tumors were pathologically staged as pT1aN0 in 18 patients, pT2N0 in 5, and pT3N0 in 2 patients; 23 tumors were typical and only two were atypical carcinoids. Morbidity was 28.0% (only minor complications), with no mortality. Overall 5-year and 10-year survival was 100.0% and 91.8%, respectively. No recurrence of the primary tumor was observed in any case.
Two-stage surgery consisting of endoscopic resection and pure bronchoplasty without lung parenchyma resection is an effective technique for the treatment of endobronchial carcinoid, with an excellent oncologic outcome.
本研究的目的是评估对于支气管内类癌患者,采用内镜切除后单纯支气管成形术且不进行任何肺切除的联合治疗方法的疗效。
我们对25例(10例男性,15例女性)支气管内类癌肿瘤患者应用了两阶段技术,首先进行内镜切除,然后进行单纯支气管成形术。中位年龄为32.4岁(范围19至64岁)。该技术的适应证为单纯支气管内类癌且无淋巴结受累。18例患者(72%)肿瘤位于右侧,7例患者(28%)位于左侧。所有患者均进行了柔性支气管镜检查作为第一阶段手术,以减少肿瘤体积并寻找肿瘤的真正蒂部。作为第二阶段手术进行了不同类型的单纯支气管成形术,并进行了系统性纵隔淋巴结清扫。
所有病例切除均为完整切除(R0)。18例患者肿瘤病理分期为pT1aN0,5例为pT2N0,2例为pT3N0;23个肿瘤为典型类癌,仅2个为非典型类癌。发病率为28.0%(仅为轻微并发症),无死亡病例。总体5年和10年生存率分别为100.0%和91.8%。任何病例均未观察到原发肿瘤复发。
由内镜切除和不切除肺实质的单纯支气管成形术组成的两阶段手术是治疗支气管内类癌的有效技术,具有出色的肿瘤学结局。